Monday, June 15, 2026 Evidence-led medical research news
The First Cohort
Medical research, with the receipts

Latest

Drugs & FDA

A Fentanyl Vaccine for Mice. An Overdose Decline for Humans.

Scripps Research published a clever chemistry redesign that let mice's immune systems recognize an entire class of fentanyl analogues. The headlines called it an overdose blocker. The mice are doing fine. Humans are years away, and the overdose decline is already happening without it.

Brain & Aging

Brain Gains Into Your 90s Are Probably Real. The Index Measuring Them Has a Patent Pending.

A three-year UT Dallas study tracking nearly 4,000 adults to age 94 says brain function can climb at any age. The biology is plausible. The catch is that the people measuring the gain are the same people patenting the yardstick.

Infectious Disease

The Battlefield Medicine Revolution Was Built on Fake Wounds

A British prosthetics graduate is heading to NHS ambulance crews and the British military to build realistic trauma wounds, the artisan end of the twenty-year battlefield-medicine revolution that turned hemorrhage into a survivable injury.

Autoimmune & Inflammation

Your Thymus Quietly Stages a Lung. Researchers Just Named the Cell Playing the Part.

A new Nature Immunology study identifies an alveolar lung-like cell hiding inside the thymus, where it appears to teach the immune system not to attack your real lungs.

Cancer

A Korean lab found cancer's DNA-repair off-switch. In a mouse.

A Korean state lab reports that a tool compound called UNI418 strips out the DNA-repair proteins cancer cells use to escape PARP inhibitors. The data are preclinical: cell lines and mouse xenografts. UNI418 is not yet a drug.

Autoimmune & Inflammation

A near-starvation diet shifted inflammation in gum-disease patients. The trial was tiny, and the diet came in a box.

A 28-patient feasibility trial put severe gum-disease patients on three cycles of a 750-calorie ProLon diet. Inflammation markers trended lower; clinical gum measures weren't reported. The biology question is real; the data is thin.

Drugs & FDA

Medicare's Product-Hopping Loophole Is Back On The Chopping Block. The Bigger Pharma Giveaway Isn't.

The Trump administration on Thursday proposed closing the product-hopping loophole that lets drugmakers reset Medicare's negotiation clock by tweaking inactive ingredients. It is the same fix the same administration quietly tabled in October.

Brain & Aging

The Same Mutations That Drive Blood Cancer Keep Turning Up in Alzheimer's Brains

A new Cell paper finds Alzheimer's brains are riddled with the same mutations that drive blood cancers, in the immune cells that are supposed to be protecting neurons.

From Investigations

All Investigations →